⁶⁸Ga-DOTATATE PET/CT versus ¹¹¹In-octreotide scintigraphy in patients with neuroendocrine tumors: a prospective study

PET/CT com ⁶⁸Ga-DOTATATE versus cintilografia com ¹¹¹In-octreotide em pacientes com tumores neuroendócrinos: estudo prospectivo

Marcelo Cavicchioli^a; Almir Galvão Vieira Bitencourt^b; Eduardo Nóbrega Pereira Lima^c

• Article
• About the authors
• Statistics
• Comments
• Related content

This work is licensed under an Attribution 4.0 International License (CC BY 4.0), effective June 9, 2022. Previously, the journal was licensed under a Creative Commons Attribution - Non-Commercial - Share Alike 4.0 International License.